← Back to Clinical Trials
Recruiting NCT07042399

NCT07042399 Self-care Behaviors of Type 2 Diabetes Mellitus Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07042399
Status Recruiting
Phase
Sponsor University of Milano Bicocca
Condition Type 2 Diabetes
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2024-03-01
Primary Completion 2027-05-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 300 participants in total. It began in 2024-03-01 with a primary completion date of 2027-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to explore the experience of the chronic disease, with a particular focus on self-care, in adults with type 2 diabetes mellitus. The main questions it aims to answer are: * what is the association between self-care and glycated hemoglobin over time? * what are participants' clinical and sociodemographic characteristics influencing self-care behaviors? Participants' socio-demographic and clinical data will be collected by medical records and, at the beginning or at the end of the clinical standard outpatient visit, they will be asked to complete study questionnaires. The results of this study could be helpful in providing quality assistance, improving resource consumption, and reducing the onset of complications.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of type 2 diabetes; * Age over 18 years old; * Adequate comprehension of the Italian language; * Signed and dated informed consent. Exclusion Criteria: * Presence of documented psychiatric or neurodegenerative disease; * Pregnancy; * Any condition that, by the investigators' judgment, may limit adherence to study procedures

Contact & Investigator

Central Contact

Davide LL Ausili

✉ davide.ausili@unimib.it

📞 +39 0264488032

Principal Investigator

Davide LL Ausili

STUDY DIRECTOR

Università degli Studi di Milano - Bicocca

Frequently Asked Questions

Who can join the NCT07042399 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07042399 currently recruiting?

Yes, NCT07042399 is actively recruiting participants. Contact the research team at davide.ausili@unimib.it for enrollment information.

Where is the NCT07042399 trial being conducted?

This trial is being conducted at San Donato Milanese, Italy, Monza, Italy.

Who is sponsoring the NCT07042399 clinical trial?

NCT07042399 is sponsored by University of Milano Bicocca. The principal investigator is Davide LL Ausili at Università degli Studi di Milano - Bicocca. The trial plans to enroll 300 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology